摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Norethisterone-3-oxime | 714964-42-8

中文名称
——
中文别名
——
英文名称
Norethisterone-3-oxime
英文别名
(3E,8R,9S,10R,13S,14S,17R)-17-ethynyl-3-hydroxyimino-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol
Norethisterone-3-oxime化学式
CAS
714964-42-8
化学式
C20H27NO2
mdl
——
分子量
313.4
InChiKey
CACLDHHVRLSJEY-ONWYLSRGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    23
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    52.8
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    炔诺酮盐酸羟胺吡啶乙醚水合甲醇甲醇 作用下, 以 吡啶 为溶剂, 反应 48.25h, 以to yield 1.93 g (95%) of norethindrone oxime, mp 121.5°-123°C的产率得到Norethisterone-3-oxime
    参考文献:
    名称:
    Prolonged release of antifertility drugs
    摘要:
    具有增强效果和延长释放抗生育药物的抗生育药物复合物。该复合物包括抗生育药物、多元酸和多价金属离子。抗生育药物以碱性胺衍生物的形式存在。
    公开号:
    US03968105A1
点击查看最新优质反应信息

文献信息

  • Process for the preparation of 3-oximino steroids
    申请人:Villa Marco
    公开号:US20060035872A1
    公开(公告)日:2006-02-16
    The present invention provides a method of preparing norelgestromin or norgestimate by reacting the corresponding 3-oxosteroid precursor with hydroxylamine HCl and a base to obtain a reaction mixture forming norelgestromin or norgestimate; monitoring the anti/syn ratio of the norelgestromin or norgestimate produced in the reaction mixture; adding a base to the reaction mixture to neutralize acidity in the reaction mixture when a desired anti/syn ratio is detected; and isolating the norelgestromin or norgestimate. The present invention also provides a process allowing a control of the formation of the anti isomer and syn isomer of norelgestromin or norgestimate by reacting the corresponding 3-oxosteroid precursor with hydroxylamine HCl and a base to obtain a reaction mixture forming norelgestromin or norgestimate; regulating the acidity of the reaction mixture to adjust the anti/syn ratio of the norelgestromin or norgestimate produced in the reaction mixture; adding a base to the reaction mixture to neutralize acidity in the reaction mixture when a desired anti/syn ratio is detected; and isolating the norelgestromin or norgestimate.
    本发明提供了一种通过将相应的3-氧代类固醇前体与羟胺盐酸和碱反应以获得形成诺酮炔酮或诺酮炔酮的反应混合物的方法;监测在反应混合物中产生的诺酮炔酮或诺酮炔酮的反式/顺式比例;当检测到所需的反式/顺式比例时,向反应混合物中添加碱以中和反应混合物中的酸性;并分离诺酮炔酮或诺酮炔酮。本发明还提供了一种允许控制诺酮炔酮或诺酮炔酮的反式异构体和顺式异构体形成的过程,该过程包括通过将相应的3-氧代类固醇前体与羟胺盐酸和碱反应以获得形成诺酮炔酮或诺酮炔酮的反应混合物;调节反应混合物的酸性以调整在反应混合物中产生的诺酮炔酮或诺酮炔酮的反式/顺式比例;当检测到所需的反式/顺式比例时,向反应混合物中添加碱以中和反应混合物中的酸性;并分离诺酮炔酮或诺酮炔酮。
  • PROCESS FOR THE PREPARATION OF 3-OXIMINO STEROIDS
    申请人:Sicor Inc.
    公开号:EP1778716A1
    公开(公告)日:2007-05-02
  • US3968105A
    申请人:——
    公开号:US3968105A
    公开(公告)日:1976-07-06
  • [EN] PROCESS FOR THE PREPARATION OF 3-OXIMINO STEROIDS<br/>[FR] PROCEDE DE PREPARATION DE STEROIDES 3-OXYMINO
    申请人:SICOR INC
    公开号:WO2006020885A1
    公开(公告)日:2006-02-23
    The present invention provides a method of preparing norelgestromin or norgestimate by reacting the corresponding 3-oxosteroid precursor with hydroxylamine HCl and a base to obtain a reaction mixture forming norelgestromin or norgestimate; monitoring the anti/syn ratio of the norelgestromin or norgestimate produced in the reaction mixture; adding a base to the reaction mixture to neutralize acidity in the reaction mixture when a desired anti/syn ratio is detected; and isolating the norelgestromin or norgestimate. The present invention also provides a process allowing a control of the formation of the anti isomer and syn isomer of norelgestromin or norgestimate by reacting the corresponding 3-oxosteroid precursor with hydroxylamine HCl and a base to obtain a reaction mixture forming norelgestromin or norgestimate; regulating the acidity of the reaction mixture to adjust the anti/syn ratio of the norelgestromin or norgestimate produced in the reaction mixture; adding a base to the reaction mixture to neutralize acidity in the reaction mixture when a desired anti/syn ratio is detected; and isolating the norelgestromin or norgestimate.
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B